These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7530029)

  • 21. Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management.
    Koster A; Fischer T; Praus M; Haberzettl H; Kuebler WM; Hetzer R; Kuppe H
    Anesthesiology; 2002 Oct; 97(4):837-41. PubMed ID: 12357148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of preoperative aspirin therapy on platelet function in cardiac surgery.
    Boldt J; Knothe C; Zickmann B; Herold C; Dapper F; Hempelmann G
    Eur J Cardiothorac Surg; 1992; 6(11):598-602. PubMed ID: 1449813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: the results of a pilot study.
    Velik-Salchner C; Maier S; Innerhofer P; Kolbitsch C; Streif W; Mittermayr M; Praxmarer M; Fries D
    Anesth Analg; 2009 Jun; 108(6):1747-54. PubMed ID: 19448196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nafamostat mesilate reduces blood loss during open heart surgery.
    Murase M; Usui A; Tomita Y; Maeda M; Koyama T; Abe T
    Circulation; 1993 Nov; 88(5 Pt 2):II432-6. PubMed ID: 8222190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aprotinin. A review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery.
    Davis R; Whittington R
    Drugs; 1995 Jun; 49(6):954-83. PubMed ID: 7543841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparin, platelet aggregation, neutrophils, and cardiopulmonary bypass.
    Belcher PR; Muriithi EW; Milne EM; Wanikiat P; Wheatley DJ; Armstrong RA
    Thromb Res; 2000 May; 98(4):249-56. PubMed ID: 10822071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?
    Zimmermann N; Kurt M; Wenk A; Winter J; Gams E; Hohlfeld T
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does platelet size correlate with function in patients undergoing cardiac surgery?
    Boldt J; Zickmann B; Benson M; Dapper F; Hempelmann G; Schindler E
    Intensive Care Med; 1993; 19(1):44-7. PubMed ID: 8440798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of acute preoperative plasmapheresis on coagulation tests, fibrinolysis, blood loss and transfusion requirements in cardiac surgery.
    Menges T; Welters I; Wagner RM; Boldt J; Dapper F; Hempelmann G
    Eur J Cardiothorac Surg; 1997 Mar; 11(3):557-63. PubMed ID: 9105824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Influence of preoperative treatment with aspirin or heparin on platelet function and intensity of postoperative bleeding in early period after coronary artery bypass surgery].
    Veikutiene A; Sirvinskas E; Grybauskas P; Cimbolaityte J; Mongirdiene A; Veikutis V
    Medicina (Kaunas); 2005; 41(7):577-83. PubMed ID: 16062025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy.
    Boldt J; Suttner S; Brosch C; Lehmann A; Röhm K; Mengistu A
    Anesth Analg; 2009 Dec; 109(6):1752-62. PubMed ID: 19923501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of aspirin or heparin on platelet function and postoperative blood loss after coronary artery bypass surgery.
    Sirvinskas E; Veikutiene A; Grybauskas P; Cimbolaityte J; Mongirdiene A; Veikutis V; Raliene L
    Perfusion; 2006 Jan; 21(1):61-6. PubMed ID: 16485701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aprotinin prevents cardiopulmonary bypass-induced platelet dysfunction. A scanning electron microscope study.
    Mohr R; Goor DA; Lusky A; Lavee J
    Circulation; 1992 Nov; 86(5 Suppl):II405-9. PubMed ID: 1385010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin Dose and Point-of-Care Measurements of Hemostasis in Cardiac Surgery-Results of a Randomized Controlled Trial.
    Lax M; Pesonen E; Hiippala S; Schramko A; Lassila R; Raivio P
    J Cardiothorac Vasc Anesth; 2020 Sep; 34(9):2362-2368. PubMed ID: 32127275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting.
    Lindvall G; Sartipy U; van der Linden J
    Ann Thorac Surg; 2005 Sep; 80(3):922-7. PubMed ID: 16122456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of pretreatment with omega-3 polyunsaturated fatty acids (PUfas) on hematological parameters and platelets aggregation in patients during elective coronary artery bypass grafting.
    Veljović M; Mihajlović I; Subota V; Antunović M; Jevdjić J; Udovicić I; Popadić A; Vulović T
    Vojnosanit Pregl; 2013 Apr; 70(4):396-402. PubMed ID: 23700945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of high-dose aprotinin on anticoagulation, heparin requirement, and celite- and kaolin-activated clotting time in heparin-pretreated patients undergoing open-heart surgery. A double-blind, placebo-controlled study.
    Dietrich W; Dilthey G; Spannagl M; Jochum M; Braun SL; Richter JA
    Anesthesiology; 1995 Oct; 83(4):679-89; discussion 29A-30A. PubMed ID: 7574046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin influences human platelet behavior in cardiac surgery with or without cardiopulmonary bypass.
    Laga S; Bollen H; Arnout J; Hoylaerts M; Meyns B
    Artif Organs; 2005 Jul; 29(7):541-6. PubMed ID: 15982282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of two doses of aprotinin in patients receiving aspirin before coronary bypass surgery.
    Moran SV; Lema G; Medel J; Irarrazaval MJ; Zalaquett R; Garayar B; Flaskamp R
    Perfusion; 2000 Mar; 15(2):105-10. PubMed ID: 10789564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban.
    Koster A; Kukucka M; Bach F; Meyer O; Fischer T; Mertzlufft F; Loebe M; Hetzer R; Kuppe H
    Anesthesiology; 2001 Feb; 94(2):245-51. PubMed ID: 11176088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.